Table 2.

Relative levels of MLL WT to chimeric fusion transcript in primary AML with greater than 70% blasts and with the MLL balanced translocation of t(9;11)(p22;q23)


Primary AML with t(9;11)(p22;q23), UPN

Relative amount of MLL WT to MLL-AF9 fusion, mean ± SD*
1   1.04 ± 0.41  
2   0.87 ± 0.09  
3   3.75 ± 0.89  
4
 
11.8 ± 1.07
 

Primary AML with t(9;11)(p22;q23), UPN

Relative amount of MLL WT to MLL-AF9 fusion, mean ± SD*
1   1.04 ± 0.41  
2   0.87 ± 0.09  
3   3.75 ± 0.89  
4
 
11.8 ± 1.07
 
*

Assays were performed in triplicate

or Create an Account

Close Modal
Close Modal